Guy Hechmati, MD, MSc

Research Reports

KRAS/RAS Testing Is Associated With Reduced Risk of Treatment Discontinuation in Patients With Metastatic Colorectal Cancer

08/22/2018

Andrew J. Klink , PhD, MPH;

Bruce A. Bach , MD, PhD;

Urvi Mujumdar , MPH;

Bruce A. Feinberg , DO;

Alexandra Christodoulopoulou , MSc;

Marwan Fakih , MD;

Guy Hechmati , MD, MSc;

Abstract: Current clinical guidelines recommend that all patients with metastatic colorectal cancer (mCRC) have tumor tissue genotyped for RAS mutations. This study aimed to evaluate patient characteristics and...

...

08/22/2018

Journal of Clinical Pathways

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Upcoming Events

March 23 ⁠–⁠ March 24

April 27 ⁠–⁠ April 28

Great Debates & Updates in Diabetic Foot

November 30 ⁠–⁠ December 2

November 27 ⁠–⁠ November 29

December 12 ⁠–⁠ December 13

May 13 ⁠–⁠ May 14

February 2 ⁠–⁠ February 5

February 27 ⁠–⁠ March 1

March 17 ⁠–⁠ March 19

See Full Calendar

Guy Hechmati, MD, MSc

Featured Webinar

Upcoming Events

Specialties

Events

Year Round Education

HMP Global Products